Result 1 - 10 of total 166
NeuroTransmitter
| Keywords | covid19 |
|---|---|
| Publisher | PMC |
| Document type | Article ; Online |
| DOI | 10.1007/s15016-020-7464-3 |
| Database | COVID19 |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
2023 Volume 50, Issue 6, Page(s) 321–325
Abstract: Objective: To analyse changes in frequencies of test psychology examinations (TPE) relevant to detect change in dementia diagnosis in general (GP) and neuropsychiatric (NP) practices during the Covid 19 pandemic.: Methods: Cross-sectional study ... ...
| Title translation | Dementia Screening and Test Psychology in German General and Specialist Practices under Conditions of the Corona Pandemic. |
|---|---|
| Abstract | Objective: To analyse changes in frequencies of test psychology examinations (TPE) relevant to detect change in dementia diagnosis in general (GP) and neuropsychiatric (NP) practices during the Covid 19 pandemic. Methods: Cross-sectional study analysis comparing the number of patients aged ≥ 70 with at least one TPE in 908 GP and 107 NP-practices in 2018-2019 (prepandemic) and 2020-2021 (pandemic) using descriptive statisics and correlations. Results: While there was a large decrease in TPE between 2018-2019 and 2020-2021 (- 18.4%) conducted in NP-practices, it remained stable in GP-practices (+ 2.6%). In both GP and NP, there was a strong correlation between the number of patients tested and newly diagnosed with dementia. Conclusion: TPE in performing in GP practices appears less susceptible to a pandemic-related decline in the provision compared to NP practices. Further research is needed to reveal the reasons for these differences. |
| MeSH term(s) | Humans ; Cross-Sectional Studies ; Pandemics ; COVID-19/epidemiology ; Germany ; Dementia/diagnosis ; Dementia/epidemiology ; Dementia/psychology |
| Language | German |
| Publishing date | 2023-05-09 |
| Publishing country | Germany |
| Document type | English Abstract ; Journal Article |
| ZDB-ID | 124981-2 |
| ISSN | 1439-0876 ; 0303-4259 |
| ISSN (online) | 1439-0876 |
| ISSN | 0303-4259 |
| DOI | 10.1055/a-2043-9939 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.A 971: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
2024 Volume 11, Page(s) 1320489
Abstract: Purpose: Urologists' practices reported decreasing medical care provision and increasing stress experience in the first wave of the COVID-19 pandemic. However, long-term effects of the pandemic are unknown.: Methods: Medical record data of n = 127 ... ...
| Abstract | Purpose: Urologists' practices reported decreasing medical care provision and increasing stress experience in the first wave of the COVID-19 pandemic. However, long-term effects of the pandemic are unknown. Methods: Medical record data of n = 127 urologists were used to assess changes in healthcare provision, comparing the pandemic with the pre-pandemic period. An online survey among n = 101 urologists was conducted to assess the physicians' perceptions of the identified healthcare provision and organizational changes and experiences of anxiety, stress, and support needs during the pandemic waves. Urologists consultations, specialists' referrals, hospital admissions, documented cancer diagnoses, urologists' perceptions of causes for these changes and experienced stress, anxiety and support needs. Results were demonstrated using descriptive statistics. Results: Over the first two years of the pandemic, there was a slight decline in consultations (-0,94%), but more intensive reduction in hospital admissions (-13,6%) and identified cancer diagnoses (-6,2%). Although patients' behavior was seen as the main reason for the changes, 71 and 61% of consultations of high-risk patients or urgent surgeries were canceled. Telemedical approaches were implemented by 58% of urologists, and 88% stated that the reduced cancer detection rate would negatively affect patients' outcomes. Urologists reported higher anxiety, stress, and need for support during all waves of the pandemic than other disciplines, especially females. Conclusion: The pandemic tremendously affects urologists' health care provision and stress experience, possibly causing long-term consequences for patients and physicians. |
|---|---|
| Language | English |
| Publishing date | 2024-02-09 |
| Publishing country | Switzerland |
| Document type | Journal Article |
| ZDB-ID | 2775999-4 |
| ISSN | 2296-858X |
| ISSN | 2296-858X |
| DOI | 10.3389/fmed.2024.1320489 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
2023 Volume 51, Issue 1, Page(s) 45–48
Abstract: Background: A current prevalence estimate predicted the number of people with dementia (PwD) with 1.8 million in 2021. This estimation is based on data from different sources especially from field studies and does not reflect the recognized and ... ...
| Title translation | Comparison of the Documented Dementia Diagnoses in German Primary Care with the Prevalence Estimate for 2021. |
|---|---|
| Abstract | Background: A current prevalence estimate predicted the number of people with dementia (PwD) with 1.8 million in 2021. This estimation is based on data from different sources especially from field studies and does not reflect the recognized and documented cases in primary care. We, therefore, aim to compare the prevalence of diagnosed PwD in general practitioner (GP) practices with these estimates of the general population. Methods: The number of diagnosed PwD in 946 GP practices with 2.8 million patients in 2021 was compared with the prevalence estimate of the German Alzheimer Society for 83 million inhabitants in Germany. Results: Dementia diagnoses were documented less frequently in GP practices compared to the prevalence estimate (1.88% vs 2.16%), especially the age groups 80+years were less likely present in GP practices prevalence. Discussion: There is still potential for optimizing dementia diagnostics in primary care, especially in patients 80 or older. |
| MeSH term(s) | Humans ; Aged, 80 and over ; Dementia/diagnosis ; Dementia/epidemiology ; Prevalence ; Germany/epidemiology ; General Practitioners ; Primary Health Care |
| Language | German |
| Publishing date | 2023-10-09 |
| Publishing country | Germany |
| Document type | English Abstract ; Journal Article |
| ZDB-ID | 124981-2 |
| ISSN | 1439-0876 ; 0303-4259 |
| ISSN (online) | 1439-0876 |
| ISSN | 0303-4259 |
| DOI | 10.1055/a-2160-2864 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.A 971: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Journal of Alzheimer's disease reports
2022 Volume 6, Issue 1, Page(s) 641–650
Abstract: Background: Previous studies revealed that low-value medication (LvM), drugs that provide little or no benefit but have the potential to cause harm, are associated with hospitalizations in dementia. Recommended medications, referred to as high-value ... ...
| Abstract | Background: Previous studies revealed that low-value medication (LvM), drugs that provide little or no benefit but have the potential to cause harm, are associated with hospitalizations in dementia. Recommended medications, referred to as high-value medication (HvM), can be used alternately. However, the effect of LvM and HvM on hospitalizations is uncertain. Objective: To determine the prevalence of LvM and HvM in hospitalized and non-hospitalized patients living with dementia (PwD) and the odds for hospital referrals in PwD receiving LvM or HvM. Methods: The analysis was based on 47,446 PwD who visited a general practitioner practice between 2017 and 2019. Different guidelines were used to elicit LvM and HvM, resulting in 185 LvM and HvM related recommendations. Of these, 117 recommendations (83 for LvM, 34 for HvM) were categorized into thirteen therapy classes. The association of hospital referrals issued by general practitioners and receiving LvM or HvM was assessed using multiple logistic regression models. Results: 20.4% of PWD received LvM. Most frequently prescribed LvM were non-recommended sedatives and hypnotics, analgesics, and antidepressants. Recommended HvM were 3.4 (69.9%) more frequently prescribed than LvM. Most commonly prescribed HvM were recommended antihypertensives, antiplatelet agents, and antiarrhythmics. Both receiving LvM and receiving HvM were associated with higher odds for hospital referrals. When receiving LvM were compared to HvM, no significant differences could be found in hospital referrals. Conclusion: LvM is highly prevalent but did not cause more likely hospital referrals than HvM. Further research should focus on acute hospitalizations, not only on planned hospital referrals. |
|---|---|
| Language | English |
| Publishing date | 2022-10-18 |
| Publishing country | Netherlands |
| Document type | Journal Article |
| ISSN | 2542-4823 |
| ISSN (online) | 2542-4823 |
| DOI | 10.3233/ADR-220004 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
Parkinsonism & related disorders
2022 Volume 99, Page(s) 101–104
Abstract: Background: We here report the pre-diagnostic clinical presentations of patients with Multiple System Atrophy (MSA) from analysis of a large routine clinical care database.: Methods: Data were extracted from a primary care database in the German ... ...
| Abstract | Background: We here report the pre-diagnostic clinical presentations of patients with Multiple System Atrophy (MSA) from analysis of a large routine clinical care database. Methods: Data were extracted from a primary care database in the German healthcare system for the period between January 2000 and December 2020. We identified 250 patients with new diagnosis of MSA and 250 controls matched for age, sex, and index year. Logistic regression analyses were conducted to assess association between MSA and predefined diagnoses. Results: The greatest rate increase in the 2 years preceding diagnosis of MSA was seen for hypotension and balance impairment but rates of memory problems, urinary dysfunction, dizziness and depression rates were also markedly increased, and ataxia was solely identified in those with a later diagnosis of MSA. Up to 5 years before diagnosis similar patterns were seen, but >5 years before diagnosis only depression rates were increased with a trend for increase in constipation. Conclusions: Presentations that were significantly more common in patients with MSA in the pre-diagnostic phase than in controls were autonomic complaints such as postural hypotension, urinary and bowel dysfunction, and early balance impairment. However, the study also highlights that memory complaints and depression may be early features of MSA years before diagnosis. |
|---|---|
| MeSH term(s) | Autonomic Nervous System ; Case-Control Studies ; Humans ; Hypotension, Orthostatic ; Multiple System Atrophy/complications ; Multiple System Atrophy/diagnosis ; Primary Health Care |
| Language | English |
| Publishing date | 2022-03-08 |
| Publishing country | England |
| Document type | Journal Article ; Research Support, Non-U.S. Gov't |
| ZDB-ID | 1311489-x |
| ISSN | 1873-5126 ; 1353-8020 |
| ISSN (online) | 1873-5126 |
| ISSN | 1353-8020 |
| DOI | 10.1016/j.parkreldis.2022.02.003 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.A 4553: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
|||
| Zs.MO 420: Show issues |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Journal of Alzheimer's disease : JAD
2022 Volume 86, Issue 2, Page(s) 703–709
Abstract: Background: Clinical trials have demonstrated a significant effectiveness of Ginkgo biloba therapy versus placebo in patients with dementia.: Objective: The present study aims to analyze the impact of Ginkgo biloba drug prescriptions on dementia ... ...
| Abstract | Background: Clinical trials have demonstrated a significant effectiveness of Ginkgo biloba therapy versus placebo in patients with dementia. Objective: The present study aims to analyze the impact of Ginkgo biloba drug prescriptions on dementia incidence in patients with mild cognitive impairment (MCI) in a real-world setting. Methods: This retrospective study was based on the IQVIA Disease Analyzer database and included patients aged 65 or older with a first diagnosis of MCI from January 2000 to December 2019. Each patient was followed for up to 20 years after MCI diagnosis until February 2021. Date of the first diagnosis of dementia or loss to follow-up, whichever occurred first, was noted. To estimate the association between Ginkgo biloba prescriptions during the follow-up and dementia incidence, a multivariable Cox regression analysis was performed, adjusted for age, sex, health insurance, documented co-diagnoses, and prescription of cholinesterase inhibitors. Results: Overall, 24,483 MCI patients (mean age: 77.0 years, 56.3% women) were included. It was found that > 2 prescriptions of Ginkgo biloba were significantly associated with a reduced dementia incidence (HR: 0.71 (95% CI: 0.55-0.91), p = 0.007), as compared with no Ginkgo biloba prescription. The effect of receiving > 3 Ginkgo biloba prescriptions was even stronger, with an HR of 0.64 (95% CI: 0.48-0.86), p = 0.003), while for > 4 prescriptions the HR was 0.58 (95% CI: 0.41-0.82) (p = 0.002). Conclusion: All-cause dementia incidence decreased with higher numbers of Ginkgo biloba prescriptions in MCI patients. |
|---|---|
| MeSH term(s) | Aged ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/epidemiology ; Dementia/drug therapy ; Dementia/epidemiology ; Female ; Ginkgo biloba ; Humans ; Incidence ; Male ; Outpatients ; Phytotherapy ; Plant Extracts/therapeutic use ; Prescriptions ; Retrospective Studies |
| Chemical Substances | Plant Extracts ; Ginkgo biloba extract (19FUJ2C58T) |
| Language | English |
| Publishing date | 2022-04-07 |
| Publishing country | Netherlands |
| Document type | Journal Article ; Research Support, Non-U.S. Gov't |
| ZDB-ID | 1440127-7 |
| ISSN | 1875-8908 ; 1387-2877 |
| ISSN (online) | 1875-8908 |
| ISSN | 1387-2877 |
| DOI | 10.3233/JAD-215348 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.A 6084: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
2017 Volume 28, Issue 12, Page(s) 14
| Language | German |
|---|---|
| Document type | Article |
| ZDB-ID | 1362825-2 |
| ISSN | 1436-123X |
| Database | Current Contents Medicine |
| Zs.A 5037: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
2023 Volume 50, Issue 06, Page(s) 321–325
Abstract: Ziel: Häufigkeitsvergleich der testpsychologischen Untersuchungen (TPU) in Haus- und Facharztpraxen (HA, FA) vor und während der Covid-19-Pandemie.: Methoden: Deskriptiver Vergleich der durchschnittlichen ... ...
| Abstract | Ziel: Häufigkeitsvergleich der testpsychologischen Untersuchungen (TPU) in Haus- und Facharztpraxen (HA, FA) vor und während der Covid-19-Pandemie. Methoden: Deskriptiver Vergleich der durchschnittlichen Anzahl von Patienten im Alter von≥70Jahren mit mindestens einer TPU in 908 HA- und 107 FA-Praxen aus der IQVIA Disease Analyzer Datenbank zwischen den Jahren 2018–2019 (Prä-Pandemie) und 2020–2021 (Pandemie). Ergebnisse: In FA Praxen zeigte sich ein Rückgang (-18,4%) von TPU von 2018–2019 zu 2020–2021. In HA-Praxen war dies nicht der Fall (+ 2.6%). Sowohl bei HA als auch bei FA bestand eine starke Korrelation zwischen der Anzahl der Patienten mit TPU und neu diagnostizierter Demenz. Schlussfolgerung: Die Durchführung von Testungen in HA-Praxen zeigte keinen Pandemie bedingten Leistungsrückgang, welcher in FA-Praxen deutlich zu sehen war. Weitere Untersuchungen müssen folgen, um mögliche Ursachen aufzuklären. |
|---|---|
| Keywords | Covid-19-Pandemie ; Demenz ; Demenz-Screening ; Hausarzt ; Facharzt ; COVID-19 pandemic ; dementia ; dementia screening ; primary care physician ; specialist |
| Language | German |
| Publishing date | 2023-05-09 |
| Publisher | Georg Thieme Verlag |
| Publishing place | Stuttgart ; New York |
| Document type | Article |
| ZDB-ID | 124981-2 |
| ISSN | 1439-0876 ; 0303-4259 |
| ISSN (online) | 1439-0876 |
| ISSN | 0303-4259 |
| DOI | 10.1055/a-2043-9939 |
| Database | Thieme publisher's database |
| Zs.A 971: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Journal of the American Medical Directors Association
2019 Volume 20, Issue 6, Page(s) 790–791
| MeSH term(s) | Antihypertensive Agents ; Cognition ; Dementia ; Humans ; Hypertension ; Incidence ; United Kingdom |
|---|---|
| Chemical Substances | Antihypertensive Agents |
| Language | English |
| Publishing date | 2019-04-11 |
| Publishing country | United States |
| Document type | Letter ; Comment |
| ZDB-ID | 2171030-2 |
| ISSN | 1538-9375 ; 1525-8610 |
| ISSN (online) | 1538-9375 |
| ISSN | 1525-8610 |
| DOI | 10.1016/j.jamda.2019.03.004 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.A 5971: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.